{{Rsnum
|rsid=7849973
|Gene=GFRA3
|Chromosome=9
|position=22819577
|Orientation=plus
|GMAF=0.2759
|Gene_s=GFRA3
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;G)
| geno3=(G;G)
| CEU | 41.1 | 45.5 | 13.4
| HCB | 83.9 | 15.3 | 0.7
| JPT | 48.7 | 47.8 | 3.5
| YRI | 72.1 | 27.2 | 0.7
| ASW | 57.9 | 26.3 | 15.8
| CHB | 83.9 | 15.3 | 0.7
| CHD | 83.5 | 16.5 | 0.0
| GIH | 30.7 | 47.5 | 21.8
| LWK | 63.3 | 32.1 | 4.6
| MEX | 22.4 | 58.6 | 19.0
| MKK | 61.9 | 34.8 | 3.2
| TSI | 38.2 | 50.0 | 11.8
| HapMapRevision=28
}}{{PMID Auto GWAS
  |PMID=23453885
  |Trait=Autism spectrum disorder, attention deficit-hyperactivity disorder, bipolar disorder, major depressive disorder, and schizophrenia (combined)
  |Title=Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis.
  |RiskAllele=
  |Pval=8E-6
  |OR=1.05
  |ORtxt=[1.02-1.08]
  |OA=1
}}

{{on chip | Affy GenomeWide 6}}